According to our (Global Info Research) latest study, the global Vinblastinesulphate market size was valued at US$ 23.1 million in 2024 and is forecast to a readjusted size of USD 24.9 million by 2031 with a CAGR of 1.1% during review period.
Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin"s disease, non-Hodgkin"s lymphoma (cancer of the lymph cells), Kaposi"s sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Global Vinblastinesulphate (CAS 143-67-9) key players include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, etc. Global top four manufacturers hold a share about 60%.
China is the largest market, with a share about 40%, followed by Europe and USA, have a share over 40 percent.
In terms of product, 97-98% Vinblastinesulphate is the largest segment, with a share about 60%. And in terms of application, the largest application is Lymphoma, followed by Lung Cancer, Breast & Ovarian Cancer, Leukemia, ect.
This report is a detailed and comprehensive analysis for global Vinblastinesulphate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vinblastinesulphate market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Vinblastinesulphate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Vinblastinesulphate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/g), 2020-2031
Global Vinblastinesulphate market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vinblastinesulphate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vinblastinesulphate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Hubei Honch Pharmaceutical, Fine Chemicals Corporation, Hengtengfu Biological Products, Vinkem, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vinblastinesulphate market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Market segment by Application
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Major players covered
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vinblastinesulphate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vinblastinesulphate, with price, sales quantity, revenue, and global market share of Vinblastinesulphate from 2020 to 2025.
Chapter 3, the Vinblastinesulphate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vinblastinesulphate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Vinblastinesulphate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vinblastinesulphate.
Chapter 14 and 15, to describe Vinblastinesulphate sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Vinblastinesulphate. Industry analysis & Market Report on Vinblastinesulphate is a syndicated market report, published as Global Vinblastinesulphate Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Vinblastinesulphate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.